Elizabeth Smith
Direttore/Membro del Consiglio presso Inceptor Bio LLC
Profilo
Elizabeth Smith is currently the Director at Inceptor Bio LLC.
Prior to this, she worked as the Vice President-Regulatory Affairs at Dendreon Corp.
and as the Senior Vice President-Regulatory at Juno Therapeutics, Inc. from 2013 to 2018.
Ms. Smith completed her undergraduate degree at Central Washington University.
Posizioni attive di Elizabeth Smith
| Società | Posizione | Inizio |
|---|---|---|
Inceptor Bio LLC
 Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Elizabeth Smith
| Società | Posizione | Fine |
|---|---|---|
| JUNO THERAPEUTICS INC | Consigliere Generale | 01/04/2018 |
| DENDREON CORPORATION | Corporate Officer/Principal | - |
Formazione di Elizabeth Smith
| Central Washington University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
Dendreon Corp.
 Dendreon Corp. Medical SpecialtiesHealth Technology Dendreon Corp. discovers, develops and commercializes novel products for the treatment of cancer. The company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy ACI product candidates designed to stimulate an immune response in a variety of tumor types. It is an exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. Dendreon was founded by Christopher S. Henney, Edgar G. Engleman and Samuel Strober in 1992 and is headquartered in Seattle, WA. | Health Technology |
Inceptor Bio LLC
Inceptor Bio LLC BiotechnologyHealth Technology Inceptor Bio LLC operates as a biotechnology industry company. The company is headquartered in Raleigh, NC. | Health Technology |
- Borsa valori
- Insiders
- Elizabeth Smith
